Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02224677 · ClinicalTrials.gov registry record
Craniofacial Microsomia: Longitudinal Outcomes in Children Pre-Kindergarten (CLOCK)
A clinical trial of Microtia and Craniofacial Microsomia, sponsored by Seattle Children's Hospital.
- Completed
- Registry status
- 417
- Enrollment target
- 5
- Study locations
NCT02224677 is a study of Microtia and Craniofacial Microsomia that has completed, run by Seattle Children's Hospital. The registered enrollment target is 417 participants, below the 1,529-participant average among 4 other Microtia trials with a reported enrollment target (73% lower). The trial reports 5 study locations across 5 states.
The verdict
NCT02224677, a study of Microtia and Craniofacial Microsomia, has completed, sponsored by Seattle Children's Hospital.
- COMPLETED
- Registry status
- 417 participants
- Enrollment target
- 5
- Study locations
Study Summary
This study is a multi-center, longitudinal cohort study of 125 infants with craniofacial microsomia (CFM) and 100 infants without craniofacial anomalies. Participants will undergo a series of evaluations between 0-3 years of age to comprehensively evaluate the developmental status of infants and toddlers with CFM. This research design will also explore specific pathways by which CFM may lead to certain outcomes. Specifically, the study explores (1) the longitudinal relations between facial asymmetry and emotion-related facial movements and socialization; and (2) associations among ear malformations, hearing and speech deficits and cognitive outcomes. Results of this research will ultimately lead to future investigations that assess new interventions and corresponding changes in current standards of care for children with CFM.
Conditions Studied
Study Locations (5)
California
- Children's Hospital Los Angeles - Los Angeles
Illinois
- University of Illinois at Chicago - Chicago
North Carolina
- University of North Carolina - Chapel Hill
Pennsylvania
- Children's Hospital of Philadelphia - Philadelphia
Washington
- Seattle Children's Hospital - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 417 participants |
| Start Date | 2013-11 |
| Est. Completion | 2019-08-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02224677
The ClinicalTrials.gov registry entry for NCT02224677 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 417 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,529-participant average among 4 other Microtia trials with a reported enrollment target (73% lower). The listed sponsor is Seattle Children's Hospital, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Microtia appearing as the primary indexed condition, and to 0 interventions.
NCT02224677 reports 5 study locations spanning 5 distinct geographic areas - top geographies include California, Illinois, North Carolina.
Frequently Asked Questions
What is clinical trial NCT02224677 about?
NCT02224677 is a clinical study titled "Craniofacial Microsomia: Longitudinal Outcomes in Children Pre-Kindergarten (CLOCK)". This study is a multi-center, longitudinal cohort study of 125 infants with craniofacial microsomia (CFM) and 100 infants without craniofacial anomalies. Participants will undergo a series of evaluations between 0-3 years of age to comprehensively evaluate the developmental status of infants and tod...
What is the current status of trial NCT02224677?
This trial is currently completed. The enrollment target is 417 participants. The study started on 2013-11. Estimated completion is 2019-08-31.
What conditions does trial NCT02224677 study?
This clinical trial studies the following conditions: Microtia, Craniofacial Microsomia, Hemifacial Microsomia, Goldenhar Syndrome, Oculo-Auriculo-Vertebral-Syndrome.
Who is sponsoring clinical trial NCT02224677?
This trial is sponsored by Seattle Children's Hospital, which has 168 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02224677 being conducted?
This trial has 5 study locations across California, Illinois, North Carolina, Pennsylvania, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Microtia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
InterNatIonal CHildhood Leukemia Microbiome/MEtabolome Cohort
RECRUITING
-
Evaluation of the Auryzon™ EAR 2.0 System in Ear Reconstruction
RECRUITING · NA
-
Microbiome Metabolites and Alcohol in HIV to Reduce CVD RCT
RECRUITING · Phase 2
-
Craniofacial Microsomia: Accelerating Understanding of the Significance and Etiology
COMPLETED
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.